SCHEMBL5929060

SCHEMBL5929060

CCCCn1c(-c2c(CC)cccc2CC)nc(Cl)c1CN1CCCCC1C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ CNR2 P34972 3/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ DRD4 P21917 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ ALDH1A1 P00352 6/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ KCNK3 O14649 1/20 0.32
▸ TLR8 Q9NR97 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929248 0.89 KDM4E (0.33) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL5928992 0.89 CYP3A4 (0.36) CYP3A4CYP2D6KCNH2CNR2ALDH1A1
SCHEMBL5929331 0.87 ALDH1A1 (0.33) CYP3A4CYP2D6KCNH2ALDH1A1LMNA
SCHEMBL5929161 0.85 CYP3A4 (0.36) CYP3A4CYP2D6KCNH2CNR2HTR2C
SCHEMBL5929000 0.84 CYP3A4 (0.34) CYP3A4CYP2D6KCNH2CNR2ALDH1A1
SCHEMBL5929216 0.82 OPRK1 (0.39) DRD2DRD3ALDH1A1MEN1KMT2A
SCHEMBL5929210 0.82 KDM4E (0.35) CYP3A4CYP2D6KCNH2ALDH1A1LMNA
SCHEMBL5928949 0.82 KDM4E (0.49) ALDH1A1LMNAHPGDTDP1MEN1
SCHEMBL5929022 0.81 CYP3A4 (0.38) CYP3A4CYP2D6KCNH2CNR2HTR1A
SCHEMBL5929137 0.81 ADORA2B (0.38) ALDH1A1HPGDKCNK3POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 CYP3A4 983/4885CYP2D6 1634/4885KCNH2 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback